Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

GARY M PEPPER

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1881608545
CMS profile
221348
Location
JUPITER, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$4,416.89

146 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Honoraria $2,225.00 2
Food and Beverage $2,191.89 144

By paying entity

PY2021 · entire year · sorted by reported total

Page 3 of 3; records 101–146 of 146 matching records. This page contains 46 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

GARY M PEPPER

NPI 1881608545 · CMS profile ID 221348

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

JUPITER, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–146 of 146 matching records. This page contains 46 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1881608545?year=2021&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
GARY M PEPPER, NPI 1881608545, CMS profile ID 221348. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–146 of 146 matching records. This page contains 46 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1881608545?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). GARY M PEPPER, NPI 1881608545, CMS profile ID 221348. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–146 of 146 matching records. This page contains 46 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1881608545?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
GARY M PEPPER, NPI 1881608545, CMS profile ID 221348, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–146 of 146 matching records. This page contains 46 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1881608545?year=2021&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

146 matching records · $4,416.89 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 146 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–146 of 146.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Amarin Pharma Inc. $1.9304/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815157503 CMS
Novo Nordisk Inc $11.9804/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811417311 CMS
Endo Pharmaceuticals Inc. $9.9404/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 828699301 CMS
Amarin Pharma Inc. $13.7104/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815386521 CMS
Acella Pharmaceuticals, LLC $875.0004/02/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 828331861 CMS
Lilly USA, LLC $13.2704/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818552449 CMS
Amarin Pharma Inc. $3.0003/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815386533 CMS
Amgen Inc. $17.9403/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825323349 CMS
Novo Nordisk Inc $19.0103/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811417307 CMS
Novo Nordisk Inc $14.2903/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811417301 CMS
Abbott Laboratories $19.9703/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818448171 CMS
Horizon Therapeutics plc $19.9103/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797185123 CMS
AbbVie Inc. $23.4903/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795594953 CMS
SANOFI-AVENTIS U.S. LLC $16.9603/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843426201 CMS
Amarin Pharma Inc. $14.5103/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815303687 CMS
Endo Pharmaceuticals Inc. $15.6403/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 828699297 CMS
Radius Health, Inc. $18.1303/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830714105 CMS
Alfasigma USA, Inc. $16.3303/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 853044763 CMS
Amneal Pharmaceuticals LLC $13.2803/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829673661 CMS
Xeris Pharmaceuticals, Inc. $20.0803/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837439929 CMS
Lilly USA, LLC $7.8303/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818552447 CMS
AstraZeneca Pharmaceuticals LP $22.8703/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830136597 CMS
Ipsen Biopharmaceuticals, Inc $19.4702/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841906503 CMS
Novo Nordisk Inc $4.1302/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811274043 CMS
RECORDATI_RARE_DISEASES_INC. $19.3602/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 831403673 CMS
Medtronic, Inc. $15.5402/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815583397 CMS
Novo Nordisk Inc $9.4502/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810904213 CMS
Novo Nordisk Inc $22.8602/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810745755 CMS
SANOFI-AVENTIS U.S. LLC $15.6102/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843426167 CMS
Esperion Therapeutics, Inc. $17.5102/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838373417 CMS
Lilly USA, LLC $2.9602/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819101907 CMS
Amarin Pharma Inc. $12.6702/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815303685 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $27.9502/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763608942 CMS
Amgen Inc. $17.6602/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825323345 CMS
AstraZeneca Pharmaceuticals LP $23.2601/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829951243 CMS
Insulet Corporation $16.9401/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839820887 CMS
Amarin Pharma Inc. $10.0101/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815100095 CMS
Novo Nordisk Inc $20.0701/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810745749 CMS
Endo Pharmaceuticals Inc. $15.2801/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 828699293 CMS
Zealand Pharma US, Inc. $20.0601/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 800229539 CMS
Amarin Pharma Inc. $17.7501/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815157517 CMS
Amneal Pharmaceuticals LLC $15.7301/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829673657 CMS
SANOFI-AVENTIS U.S. LLC $18.3301/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843426139 CMS
Novo Nordisk Inc $16.6701/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810904207 CMS
Abbott Laboratories $22.9001/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818391557 CMS
LifeScan, Inc. $18.2701/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845331403 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $3,767.15 144
PY2020 $10,793.23 130
PY2021 $4,416.89 146
PY2022 $4,590.08 107
PY2023 $5,396.59 67
PY2024 $2,925.00 1

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2023 Principal investigator $40,131.00 17
PY2022 Principal investigator $20,505.53 9

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

17 records in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Endo Pharmaceuticals Inc. $1,500.00 10/11/2023 Non-covered Recipient Entity
METABOLIC RESEARCH INSTITUTE INC
An Open-Label, Randomized, Parallel-Group, Three Treatment Arm, Multicenter Study on Hypogonadal Males to Evaluate the Effect on 24-Hour Ambulatory Blood Pressure After 16-Week Continuous Treatment with Marketed Testosterone Products No dispute reported 06/30/2026 1033265121
Principal investigator 1 Endo Pharmaceuticals Inc. $1,500.00 10/11/2023 Non-covered Recipient Entity
METABOLIC RESEARCH INSTITUTE INC
An Open-Label, Randomized, Parallel-Group, Three Treatment Arm, Multicenter Study on Hypogonadal Males to Evaluate the Effect on 24-Hour Ambulatory Blood Pressure After 16-Week Continuous Treatment with Marketed Testosterone Products No dispute reported 06/30/2026 1033265139
Principal investigator 1 Endo Pharmaceuticals Inc. $1,562.00 07/19/2023 Non-covered Recipient Entity
METABOLIC RESEARCH INSTITUTE INC
An Open-Label, Randomized, Parallel-Group, Three Treatment Arm, Multicenter Study on Hypogonadal Males to Evaluate the Effect on 24-Hour Ambulatory Blood Pressure After 16-Week Continuous Treatment with Marketed Testosterone Products No dispute reported 06/30/2026 1033259553
Principal investigator 1 Endo Pharmaceuticals Inc. $3,729.00 06/22/2023 Non-covered Recipient Entity
METABOLIC RESEARCH INSTITUTE INC
An Open-Label, Randomized, Parallel-Group, Three Treatment Arm, Multicenter Study on Hypogonadal Males to Evaluate the Effect on 24-Hour Ambulatory Blood Pressure After 16-Week Continuous Treatment with Marketed Testosterone Products No dispute reported 06/30/2026 1033259119
Principal investigator 1 Endo Pharmaceuticals Inc. $700.00 06/14/2023 Non-covered Recipient Entity
METABOLIC RESEARCH INSTITUTE INC
An Open-Label, Randomized, Parallel-Group, Three Treatment Arm, Multicenter Study on Hypogonadal Males to Evaluate the Effect on 24-Hour Ambulatory Blood Pressure After 16-Week Continuous Treatment with Marketed Testosterone Products No dispute reported 06/30/2026 1033258753
Principal investigator 1 Endo Pharmaceuticals Inc. $235.00 06/14/2023 Non-covered Recipient Entity
METABOLIC RESEARCH INSTITUTE INC
An Open-Label, Randomized, Parallel-Group, Three Treatment Arm, Multicenter Study on Hypogonadal Males to Evaluate the Effect on 24-Hour Ambulatory Blood Pressure After 16-Week Continuous Treatment with Marketed Testosterone Products No dispute reported 06/30/2026 1033258763
Principal investigator 1 Endo Pharmaceuticals Inc. $2,000.00 06/14/2023 Non-covered Recipient Entity
METABOLIC RESEARCH INSTITUTE INC
An Open-Label, Randomized, Parallel-Group, Three Treatment Arm, Multicenter Study on Hypogonadal Males to Evaluate the Effect on 24-Hour Ambulatory Blood Pressure After 16-Week Continuous Treatment with Marketed Testosterone Products No dispute reported 06/30/2026 1033258781
Principal investigator 1 Endo Pharmaceuticals Inc. $600.00 06/14/2023 Non-covered Recipient Entity
METABOLIC RESEARCH INSTITUTE INC
An Open-Label, Randomized, Parallel-Group, Three Treatment Arm, Multicenter Study on Hypogonadal Males to Evaluate the Effect on 24-Hour Ambulatory Blood Pressure After 16-Week Continuous Treatment with Marketed Testosterone Products No dispute reported 06/30/2026 1033258793
Principal investigator 1 Endo Pharmaceuticals Inc. $1,500.00 06/14/2023 Non-covered Recipient Entity
METABOLIC RESEARCH INSTITUTE INC
An Open-Label, Randomized, Parallel-Group, Three Treatment Arm, Multicenter Study on Hypogonadal Males to Evaluate the Effect on 24-Hour Ambulatory Blood Pressure After 16-Week Continuous Treatment with Marketed Testosterone Products No dispute reported 06/30/2026 1033258807
Principal investigator 1 Endo Pharmaceuticals Inc. $235.00 06/14/2023 Non-covered Recipient Entity
METABOLIC RESEARCH INSTITUTE INC
An Open-Label, Randomized, Parallel-Group, Three Treatment Arm, Multicenter Study on Hypogonadal Males to Evaluate the Effect on 24-Hour Ambulatory Blood Pressure After 16-Week Continuous Treatment with Marketed Testosterone Products No dispute reported 06/30/2026 1033258821
Principal investigator 1 Endo Pharmaceuticals Inc. $3,729.00 04/26/2023 Non-covered Recipient Entity
METABOLIC RESEARCH INSTITUTE INC
An Open-Label, Randomized, Parallel-Group, Three Treatment Arm, Multicenter Study on Hypogonadal Males to Evaluate the Effect on 24-Hour Ambulatory Blood Pressure After 16-Week Continuous Treatment with Marketed Testosterone Products No dispute reported 06/30/2026 1033255443
Principal investigator 1 Endo Pharmaceuticals Inc. $1,731.00 03/22/2023 Non-covered Recipient Entity
METABOLIC RESEARCH INSTITUTE INC
An Open-Label, Randomized, Parallel-Group, Three Treatment Arm, Multicenter Study on Hypogonadal Males to Evaluate the Effect on 24-Hour Ambulatory Blood Pressure After 16-Week Continuous Treatment with Marketed Testosterone Products No dispute reported 06/30/2026 1033253439
Principal investigator 1 Endo Pharmaceuticals Inc. $4,971.00 03/15/2023 Non-covered Recipient Entity
METABOLIC RESEARCH INSTITUTE INC
An Open-Label, Randomized, Parallel-Group, Three Treatment Arm, Multicenter Study on Hypogonadal Males to Evaluate the Effect on 24-Hour Ambulatory Blood Pressure After 16-Week Continuous Treatment with Marketed Testosterone Products No dispute reported 06/30/2026 1033252695
Principal investigator 1 Endo Pharmaceuticals Inc. $1,050.00 03/01/2023 Non-covered Recipient Entity
METABOLIC RESEARCH INSTITUTE INC
An Open-Label, Randomized, Parallel-Group, Three Treatment Arm, Multicenter Study on Hypogonadal Males to Evaluate the Effect on 24-Hour Ambulatory Blood Pressure After 16-Week Continuous Treatment with Marketed Testosterone Products No dispute reported 06/30/2026 1033252269
Principal investigator 1 Endo Pharmaceuticals Inc. $4,143.00 03/01/2023 Non-covered Recipient Entity
METABOLIC RESEARCH INSTITUTE INC
An Open-Label, Randomized, Parallel-Group, Three Treatment Arm, Multicenter Study on Hypogonadal Males to Evaluate the Effect on 24-Hour Ambulatory Blood Pressure After 16-Week Continuous Treatment with Marketed Testosterone Products No dispute reported 06/30/2026 1033252279
Principal investigator 1 Endo Pharmaceuticals Inc. $4,015.00 02/15/2023 Non-covered Recipient Entity
METABOLIC RESEARCH INSTITUTE INC
An Open-Label, Randomized, Parallel-Group, Three Treatment Arm, Multicenter Study on Hypogonadal Males to Evaluate the Effect on 24-Hour Ambulatory Blood Pressure After 16-Week Continuous Treatment with Marketed Testosterone Products No dispute reported 06/30/2026 1033251639
Principal investigator 1 Endo Pharmaceuticals Inc. $6,931.00 01/18/2023 Non-covered Recipient Entity
METABOLIC RESEARCH INSTITUTE INC
An Open-Label, Randomized, Parallel-Group, Three Treatment Arm, Multicenter Study on Hypogonadal Males to Evaluate the Effect on 24-Hour Ambulatory Blood Pressure After 16-Week Continuous Treatment with Marketed Testosterone Products No dispute reported 06/30/2026 1033249623